Koers Laser Energetics, Inc. Other OTC
Aandelen
LNGT
US51805Q1022
Farmaceutische producten
Omzet 2004 | 2,5 mln. 2,34 mln. | Omzet 2005 | - | Marktkapitalisatie | 326 mln. 305 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2004 | - 0 | Nettowinst (verlies) 2005 | -1 mln. -935K | EV/omzet 2004 | - |
Nettoschuld 2004 | 3,72 mln. 3,48 mln. | Nettoschuld 2005 | 2,89 mln. 2,7 mln. | EV/omzet 2005 | - |
K/w-verhouding 2004 |
-22,6
x | K/w-verhouding 2005 |
-120
x | Werknemers | - |
Dividendrendement 2004 * |
-
| Dividendrendement 2005 |
-
| Vrij verhandelbaar | 69,19% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Robert Battis
CEO | Chief Executive Officer | 61 | 01-11-91 |
John T. LiVecchi
CTO | Chief Tech/Sci/R&D Officer | 72 | 01-01-97 |
Dominic Battisti
AUD | Comptroller/Controller/Auditor | 68 | 01-07-92 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John T. LiVecchi
CTO | Chief Tech/Sci/R&D Officer | 72 | 01-01-97 |
Robert Battis
CEO | Chief Executive Officer | 61 | 01-11-91 |
Gregory Quarles
BRD | Director/Board Member | 63 | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,04% | 5,92 mld. | |
-15,13% | 4,51 mld. | |
-9,75% | 3,15 mld. | |
+2,14% | 3,1 mld. | |
-6,82% | 2,42 mld. | |
+47,87% | 1,97 mld. | |
-7,89% | 1,68 mld. | |
+0,09% | 1,65 mld. | |
-12,97% | 1,53 mld. |